The median C 0 /dose level for patients with the CYP2C19 ∗ 3 GA genotype (9.43 μg·ml −1 /kg·day −1 ) was numerically higher than for those with the GG homozygous wild-type (5.78 μg·ml −1 /kg·day −1 ) genotype but this difference did not reach statistical significance ( P = .289; Table 2 ).
← all excerpts
Correlation of CYP2C19 genotype with plasma voriconazole exposure in South-western Chinese Han patients with invasive fungal infections.
1
0.2890
0.2890